Publication | Closed Access

AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species

Chemoprevention StrategyMedicineApoptosisCell DeathPulmonary PharmacologyAnti-lung Cancer ActivityAnti-cancer AgentP38 Mapk PathwayLung CancerPharmacologyCell BiologyNovel Ginsenoside DerivativeTumor MicroenvironmentCancer Research